
Join to View Full Profile
1802 6th Ave SBirmingham, AL 35233
Dr. Mudd is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
- University of Alabama Medical CenterResidency, Internal Medicine, 2023 - 2026
- Medical College of Georgia at Augusta UniversityClass of 2023
- University of GeorgiaBS, Genetics, Magna Cum Laude, 2015 - 2019
Certifications & Licensure
- AL State Medical License 2024 - 2026
Publications & Presentations
PubMed
- BPI25-016: Real-World Outcomes of Total Neoadjuvant Therapy for Locally Advanced Rectal Cancer: Insights From a Single Center in the Deep South.Todd William Mudd, Faris A Abby, Darryl Outlaw, Mehmet Akce, Bassel El-Rayes
Journal of the National Comprehensive Cancer Network. 2025-03-28 - Revisiting the Role of Day 14 Bone Marrow Biopsy in Acute Myeloid Leukemia.Omer Jamy, Garrett Bourne, Todd William Mudd, Haley Thigpen, Ravi Bhatia
Cancers. 2025-03-06 - Case report: Hyperosmolar hyperglycemic syndrome secondary to PEG-asparaginase-induced hypertriglyceridemia and pancreatitis.Todd William Mudd Jr, Ashley Danielle Fox, Mark Ghaly, Amany Keruakous
Frontiers in Oncology. 2022-01-01
Abstracts/Posters
- Real-World Outcomes of Total Neoadjuvant Therapy for Locally Advanced Rectal Cancer: Insights from a Single Center in the Deep SouthT. William Mudd MD, Faris A Abby MD, Vinod Kumar MD, Darryl Outlaw MD, Mehmet Akce MD, Bassel El-Rayes MD, Midhun Malla MD, Qasim S Hussaini MD, Garima Gupta MD, National Comprehensive Cancer Network Annual Meeting, Orlando, FL, 3/28/2025
- Mistaken Identity – AL Amyloidosis with Gastrointestinal Involvement Initially Masquerading as CirrhosisT William Mudd MD and Jori May MD, Southern Society of General Internal Medicine Regional Meeting, New Orleans, LA, 2/14/2025
- Superior Survival with Intensive Chemotherapy, Compared to Hypomethylating Agent + Venetoclax, in Patients with Intermediate/Adverse Risk Acute Myeloid Leukemia Unable...Kendall Diebold, Todd Mudd, Jay Jarodiya, Katherine Parks, Maris Hardee, Kimo Bachiashvili, Sravanti Rangaraju, Pankit Vachhani, Manuel Espinoza-Gutarra, Razan Mohty, ..., American Society of Hematology Annual Meeting, San Diego, CA, 12/7/2024
Professional Memberships
- Member
- Member
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: